Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Thorough history taking is crucial for diagnosing hypothyroidism in rheumatoid arthritis patients.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Baricitinib improved hair loss and arthritis in a lupus patient.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

Citrullinated proteins from Porphyromonas gingivalis may contribute to rheumatoid arthritis.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

The conclusion is that early diagnosis of skin signs linked to diseases like Lupus, Dermatomyositis, and Rheumatoid Arthritis is crucial to prevent serious complications.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

People with lupus and rheumatoid arthritis have thinner hair than healthy people.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

RHUPUS should be considered in children with deforming arthritis.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Weekly 5 mg folate is enough to prevent methotrexate toxicity in rheumatoid arthritis patients.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.